Ann Surg Oncol
- PARVEZ E, Bogach J, Kirkwood D, Pond G, et al
Immigration Status and Breast Cancer Surgery Quality of Care Metrics: A
Population-Level Analysis.
Ann Surg Oncol. 2024 Apr 18. doi: 10.1245/s10434-024-15250.
BMC Cancer
- GILL J, Yendamuri K, Chatterjee U, Yao S, et al
Racial/ethnic differences in 21-gene recurrence score and survival among patients
with estrogen receptor-positive breast cancer.
BMC Cancer. 2024;24:461.
BMJ
- WISE J
Breast cancer: Inaction on inequalities has led to unequal progress, say experts.
BMJ. 2024;385:q854.
Br J Cancer
- SHEN F, Jiang G, Philips S, Cantor E, et al
Germline predictors for bevacizumab induced hypertensive crisis in ECOG-ACRIN
5103 and BEATRICE.
Br J Cancer. 2024;130:1348-1355.
- BRAUN M, Piasecka D, Sadej R, Romanska HM, et al
FGFR4-driven plasticity in breast cancer progression and resistance to therapy.
Br J Cancer. 2024 Apr 17. doi: 10.1038/s41416-024-02658.
- CHANG CY, Jones BL, Hincapie-Castillo JM, Park H, et al
Association between trajectories of adherence to endocrine therapy and risk of
treated breast cancer recurrence among US nonmetastatic breast cancer survivors.
Br J Cancer. 2024 Apr 18. doi: 10.1038/s41416-024-02680.
Breast Cancer
- ZHANG HP, Jiang RY, Zhu JY, Sun KN, et al
PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in
triple-negative breast cancer.
Breast Cancer. 2024 Apr 17. doi: 10.1007/s12282-024-01567.
- ROUSSET-JABLONSKI C, Lortal B, Lantheaume S, Arnould L, et al
French national survey on breast cancer care: caregiver and patient views.
Breast Cancer. 2024 Apr 18. doi: 10.1007/s12282-024-01576.
Breast Cancer (Auckl)
- AURELL C, Haidar A, Giglio D
Follow-up Routines Matter for Adherence to Endocrine Therapy in the Adjuvant
Setting of Breast Cancer.
Breast Cancer (Auckl). 2024;18:11782234241240171.
Breast Cancer (Dove Med Press)
- YE M, Xu H, Ding J, Jiang L, et al
Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative
Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A
Literature Review.
Breast Cancer (Dove Med Press). 2024;16:181-197.
- SYAHRUDDIN FI, Prihantono, Muis M
Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast
Cancer Patients [Letter].
Breast Cancer (Dove Med Press). 2024;16:221-222.
- CHEN Y, Li WX, Wu JH, Chen GH, et al
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast
Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory
Analysis of the SYSUCC-001 Trial.
Breast Cancer (Dove Med Press). 2024;16:223-231.
- MA S, Hao R, Lu YW, Wang HP, et al
Identification and Validation of Novel Metastasis-Related Immune Gene Signature
in Breast Cancer.
Breast Cancer (Dove Med Press). 2024;16:199-219.
Breast Cancer Res
-
Meeting Abstracts from the British Society of Breast Radiology annual scientific
meeting 2023.
Breast Cancer Res. 2024;26.
- ZHANG N, Huang Y, Wang G, Xiang Y, et al
Metabolomics assisted by transcriptomics analysis to reveal metabolic
characteristics and potential biomarkers associated with treatment response of
neoadjuvant therapy with TCbHP regimen in HER2 + breast cancer.
Breast Cancer Res. 2024;26:64.
- BAE SJ, Kook Y, Jang JS, Baek SH, et al
Selective omission of sentinel lymph node biopsy in mastectomy for ductal
carcinoma in situ: identifying eligible candidates.
Breast Cancer Res. 2024;26:65.
- SALEMBIER R, De Haes C, Bellemans J, Demeyere K, et al
Chitin-mediated blockade of chitinase-like proteins reduces tumor
immunosuppression, inhibits lymphatic metastasis and enhances anti-PD-1 efficacy
in complementary TNBC models.
Breast Cancer Res. 2024;26:63.
- BAE SJ, Chun JW, Lee SB, Ryu JM, et al
Outcomes of sentinel node biopsy according to MRI response in an association with
the subtypes in cN1-3 breast cancer after neoadjuvant systemic therapy,
multicenter cohort study.
Breast Cancer Res. 2024;26:66.
Breast Cancer Res Treat
- FERNANDEZ-GONZALEZ S, Falo C, Pla MJ, Campos M, et al
Sentinel lymph node biopsy before and after neoadjuvant chemotherapy in cN0
breast cancer patients: impact on axillary morbidity and survival-a propensity
score cohort study.
Breast Cancer Res Treat. 2024 Apr 18. doi: 10.1007/s10549-024-07274.
- BALTUSSEN JC, Mooijaart SP, Vulink AJE, Houtsma D, et al
Tolerability and effectiveness of palbociclib in older women with metastatic
breast cancer.
Breast Cancer Res Treat. 2024 Apr 16. doi: 10.1007/s10549-024-07312.
- TAN CF, Wang J, Zhong XR, Dai ZL, et al
Is postmastectomy radiotherapy necessary for breast cancer patients with
clinically node-positive downstaging to ypN0 after neoadjuvant chemotherapy?
Breast Cancer Res Treat. 2024 Apr 15. doi: 10.1007/s10549-024-07249.
Cancer
- BERNSTEIN-MOLHO R, Shhada NA, Laitman Y, Netzer I, et al
Targeted genotyping for recurring variants in cancer susceptibility genes in
non-Ashkenazi Jewish patients with breast cancer diagnosed >/=50 years.
Cancer. 2024 Apr 17. doi: 10.1002/cncr.35329.
Cancer Epidemiol Biomarkers Prev
- COLLISTER JA, Liu X, Littlejohns TJ, Cuzick J, et al
Assessing the value of incorporating a polygenic risk score with non-genetic
factors for predicting breast cancer diagnosis in the UK Biobank.
Cancer Epidemiol Biomarkers Prev. 2024.
Clin Breast Cancer
- PAN W, Cheng H, Zhang J, Yang Z, et al
The FGFR2 Variant rs13387042 is Associated With Breast Cancer Risk: A
Meta-Analysis and Systematic Review.
Clin Breast Cancer. 2024 Mar 15:S1526-8209(24)00082.
- CORPUZ GS, Kim DK, Kim IE Jr, Rohde CH, et al
Existing Psychiatric Diagnoses Among Breast Cancer Patients Interact with
Outcomes After Autologous and Implant-Based Bilateral Breast Reconstruction: A
Propensity Score Matched Analysis.
Clin Breast Cancer. 2024 Mar 24:S1526-8209(24)00096.
- YADAV BS, Dey T
Hypofractionation for Regional Nodal Irradiation in Breast Cancer: Best of Both
the Worlds.
Clin Breast Cancer. 2024 Mar 14:S1526-8209(24)00080.
- DOWNS-CANNER S, Weiss A
Systemic Therapy Advances for HER2-Positive and Triple Negative Breast Cancer:
What the Surgeon Needs to Know.
Clin Breast Cancer. 2024 Mar 13:S1526-8209(24)00077.
- HU Y, Zhu Y, Shi J, Wei X, et al
Plasma Thioredoxin Reductase as a Potential Diagnostic Biomarker for Breast
Cancer.
Clin Breast Cancer. 2024 Mar 15:S1526-8209(24)00081.
- ZHANG M, Zha H, Pan J, Liu X, et al
Development of an Ultrasound-based Nomogram for Predicting Pathologic Complete
Response and Axillary Response in Node-Positive Patients with Triple- Negative
Breast Cancer.
Clin Breast Cancer. 2024 Mar 23:S1526-8209(24)00098.
Clin Cancer Res
- IWASE T, Cohen EN, Gao H, Alexander A, et al
Maintenance pembrolizumab therapy in patients with metastatic HER2-negative
breast cancer with prior response to chemotherapy.
Clin Cancer Res. 2024 Apr 17. doi: 10.1158/1078-0432.CCR-23-2947.
Eur J Cancer
- GUERINI-ROCCO E, Bellerba F, Concardi A, Taormina SV, et al
Expression of immune-related genes and breast cancer recurrence in women with
ductal carcinoma in situ.
Eur J Cancer. 2024;203:114063.
Eur J Surg Oncol
- APOSTOLOVA C, Ferroum A, Alhassan B, Prakash I, et al
Timing of genetic testing in BRCA1/2 and PALB2-Associated breast cancer:
Preoperative result disclosure increases uptake of risk-reducing mastectomy and
reduces unnecessary exposure to radiotherapy.
Eur J Surg Oncol. 2024;50:108324.
Int J Radiat Oncol Biol Phys
- PATEL TA, Jain B, Vapiwala N, Chino F, et al
Trends in Utilization and Medicare Spending on Short-Course Radiotherapy for
Breast and Prostate Cancer: An Episode-Based Analysis from 2015-2019.
Int J Radiat Oncol Biol Phys. 2023 Dec 8:S0360-3016(23)08173.
- ROGE M, Kirova Y, Leveque E, Guigo M, et al
Impact of radiation therapy modalities on loco-regional control in inflammatory
breast cancer.
Int J Radiat Oncol Biol Phys. 2024 Apr 13:S0360-3016(24)00506.
- KIM E, Yoo JS, Kim YJ, Joo J, et al
Toxicity evaluation of dose-escalation in hypofractionated regional nodal
irradiation for breast cancer: a retrospective study.
Int J Radiat Oncol Biol Phys. 2024 Apr 15:S0360-3016(24)00513.
J Nucl Med
- MOSER R, Pfeiffer S, Cala L, Klein E, et al
Detecting Metastatic Patterns of Oligometastatic Breast Cancer: A Comparative
Analysis of (18)F-FDG PET/CT and Conventional CT Imaging.
J Nucl Med. 2024 Apr 18:jnumed.123.266925. doi: 10.2967/jnumed.123.266925.
Lancet
- SAMARASEKERA U
Charlotte Coles: collaborating to tackle breast cancer inequities.
Lancet. 2024 Apr 12:S0140-6736(24)00752-9. doi: 10.1016/S0140-6736(24)00752.
- COLES CE, Earl H, Anderson BO, Barrios CH, et al
The Lancet Breast Cancer Commission.
Lancet. 2024 Apr 12:S0140-6736(24)00747-5. doi: 10.1016/S0140-6736(24)00747.
- MOODLEY J, Unger-Saldana K
The role of racial and ethnic discrimination in breast cancer disparities.
Lancet. 2024 Apr 12:S0140-6736(24)00699-8. doi: 10.1016/S0140-6736(24)00699.
Mod Pathol
- DE SCHEPPER M, Koorman T, Richard F, Christgen M, et al
Integration of pathological criteria and immunohistochemical evaluation for
invasive lobular carcinoma diagnosis: recommendations from the European Lobular
Breast Cancer Consortium.
Mod Pathol. 2024 Apr 17:100497. doi: 10.1016/j.modpat.2024.100497.
NPJ Breast Cancer
- MORGANTI S, Jin Q, Vincuilla J, Buehler R, et al
Clinicopathological characteristics and eligibility for adjuvant olaparib of
germline BRCA1/2 mutation carriers with HER2-negative early breast cancer.
NPJ Breast Cancer. 2024;10:28.
- LIEFAARD MC, van der Voort A, van Seijen M, Thijssen B, et al
Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with
neoadjuvant chemotherapy and dual HER2-blockade.
NPJ Breast Cancer. 2024;10:29.
Oncogene
- CHEN X, Ma C, Li Y, Liang Y, et al
COL5A1 promotes triple-negative breast cancer progression by activating tumor
cell-macrophage crosstalk.
Oncogene. 2024 Apr 12. doi: 10.1038/s41388-024-03030.
- ZHOU Z, Zheng X, Zhao J, Yuan A, et al
ULK1-dependent phosphorylation of PKM2 antagonizes O-GlcNAcylation and regulates
the Warburg effect in breast cancer.
Oncogene. 2024 Apr 17. doi: 10.1038/s41388-024-03035.
PLoS One
- BAHCACI U, Atasavun Uysal S, Erdogan Iyigun Z, Ordu C, et al
Progressive relaxation training in patients with breast cancer receiving
aromatase inhibitor therapy-randomized controlled trial.
PLoS One. 2024;19:e0301020.
- ABIDI O, Abdelkafi-Koubaa Z, Bettaieb-Dridi I, Toumi L, et al
Pistacia lentiscus L. revealed in vitro anti-proliferative activity on MCF-7
breast cancer cells and in vivo anti-mammary cancer effect on C57BL/6 mice
through necrosis, anti-inflammatory and antioxidant enhancements.
PLoS One. 2024;19:e0301524.
- ERDOGAN C, Suer I, Kaya M, Ozturk S, et al
Bioinformatics analysis of the potentially functional circRNA-miRNA-mRNA network
in breast cancer.
PLoS One. 2024;19:e0301995.
- ALLANA A, Shamsi U, Rashid Y, Khan FR, et al
Oral mucositis & oral health related quality of life in women undergoing
chemotherapy for breast cancer in Karachi, Pakistan: A multicenter hospital based
cross-sectional study.
PLoS One. 2024;19:e0295456.
- EUM DY, Jeong M, Park SY, Kim J, et al
AM-18002, a derivative of natural anmindenol A, enhances radiosensitivity in
mouse breast cancer cells.
PLoS One. 2024;19:e0296989.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016